Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 94Leukemia, Myeloid, Chronic-Phase 25Leukemia 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Blast Crisis 9Philadelphia Chromosome 4Myeloproliferative Disorders 4Leukemia, Myeloid 4Bone Marrow Diseases 4Recurrence 3Leukemia, Myeloid, Acute 3Leukemia, Myeloid, Accelerated Phase 3Hematologic Diseases 3Bronchiolitis Obliterans Syndrome 3Neoplasm, Residual 2Hematologic Neoplasms 2Substance Withdrawal Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Piebaldism 1Neoplastic Processes 1Neoplasms by Histologic Type 1Neoplasms 1Mastocytosis, Systemic 1Hypereosinophilic Syndrome 1Gastrointestinal Stromal Tumors 1

Interventions

midostaurin 3avapritinib 2ripretinib 1obatoclax 1nilotinib 1ibrutinib 1dexamethasone acetate 1dexamethasone 21-phosphate 1denileukin diftitox 1auricularum 1Ranitidine 1Interviews as Topic 1Imatinib Mesylate 1Ibuprofen 1Diphenhydramine 1Dexamethasone 1Calcium Dobesilate 1Brentuximab Vedotin 1Azacitidine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mastocytosis, Systemic × nilotinib × Other hematologic neoplasm × Clear all
NCT00109707 2021-06-29

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Novartis

Phase 1/2 Completed
507 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome, Mastocytosis, Systemic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡